Literature DB >> 28088990

Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations.

Avrom Caplan1, Nicole Fett2, Misha Rosenbach1, Victoria P Werth1, Robert G Micheletti3.   

Abstract

Part 3 of this 4-part continuing medical education series reviews several important infectious complications of corticosteroid use, including a focus on pneumocystis pneumonia (PCP) prophylaxis, tuberculosis, viral hepatitis, and other infections, followed by a discussion of vaccination recommendations in immunosuppressed patients.
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  glucocorticoids; infections; pneumocystis pneumonia; side effects; steroids; vaccines

Mesh：

Substances：

Year:  2017        PMID： 28088990     DOI： 10.1016/j.jaad.2016.02.1240

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  11 in total

1.  A challenging case of tuberculosis-associated uveitis after corticosteroid treatment for Vogt-Koyanagi-Harada disease.

Authors:  Tian-Wei Qian; Su-Qin Yu; Xun Xu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

2.  Analysis of therapeutic effectiveness and adverse effects of long-term corticosteroids among leprosy patients with reactions: A retrospective cohort study.

Authors:  Joyce Novelyn Siagian; Sri Linuwih Menaldi
Journal:  SAGE Open Med       Date:  2022-04-19

Review 3.  Glucocorticoid treatment in juvenile idiopathic arthritis.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-10-01       Impact factor: 2.631

4.  Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis.

Authors:  Kyle T Amber; Aniek Lamberts; Farzan Solimani; Arianna F Agnoletti; Dario Didona; Ilona Euverman; Emanuele Cozzani; Lee Haur Yueh; Giovanni Di Zenzo; Yael Anne Leshem; Daniel Mimouni; Michael Hertl; Barbara Horvath
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

Review 5.  Prevention of complications from use of conventional immunosuppressants: a critical review.

Authors:  Claudio Ponticelli; Richard J Glassock
Journal:  J Nephrol       Date:  2019-03-29       Impact factor: 4.393

6.  Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology.

Authors:  Paulo Müller Ramos; Alessandra Anzai; Bruna Duque-Estrada; Daniel Fernandes Melo; Flavia Sternberg; Leopoldo Duailibe Nogueira Santos; Lorena Dourado Alves; Fabiane Mulinari-Brenner
Journal:  An Bras Dermatol       Date:  2020-10-08       Impact factor: 1.896

Review 7.  The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

Authors:  Marie Robert; Pierre Miossec; Arnaud Hot
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

8.  Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.

Authors:  A M Drucker; K Eyerich; M S de Bruin-Weller; J P Thyssen; P I Spuls; A D Irvine; G Girolomoni; S Dhar; C Flohr; D F Murrell; A S Paller; E Guttman-Yassky
Journal:  Br J Dermatol       Date:  2018-01-28       Impact factor: 9.302

9.  Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old.

Authors:  Yuan Gong; Li Guan; Zhu Jin; Shixiong Chen; Guangming Xiang; Baoan Gao
Journal:  J Med Virol       Date:  2020-08-25       Impact factor: 20.693

10.  The System Research of the Molecular Mechanism of Quyushengxin Capsule in the Treatment of Osteonecrosis of the Femoral Head.

Authors:  Xia Du; Lintao Zhao; Yuan Qiao; Yuan Liu; Dong Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-11       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.